Pugate, Gab Ryle Cyd A.
HRN: 21-65-54 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/30/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
07/30/2022
08/06/2022
IVTT
525
Q6
PCAP
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes